Skip to main content
All lobbying filings

CVS HEALTH (AND SUBSIDIARIES)

CVS HEALTH (AND SUBSIDIARIES) filed a Q3 report for CVS HEALTH (AND SUBSIDIARIES) on October 20, 2025.

Lobbying for CVS HEALTH (AND SUBSIDIARIES) · Health Care

All filings by CVS HEALTH (AND SUBSIDIARIES) · Everything CVS HEALTH (AND SUBSIDIARIES) has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$2,150,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • KATHERINE RAAB New on this filing
    Previously held: Senior Legislative Aide, Rep. Mary Bono; Professional Staff Member, House Energy and Commerce Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7
Pharmacy

Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy

Taxation/Internal Revenue Code

Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act

Medicare/Medicaid

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act

Insurance

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025

Labor Issues/Antitrust/Workplace

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. P.L. 119-21, The One Big, Beautiful Bill Act S. 2099, The Restore Prescription Drugs Discount Act

Consumer Issues/Safety/Products

Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act

Advertising

S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025

 Bills named in this filing 17
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • S. 2426
    Equitable Community Access to Pharmacist Services Act
  • H.R. 3010
    No Handouts for Drug Advertisements Act
  • S. 1785
    No Handouts for Drug Advertisements Act
  • S. 882
    Patients Before Middlemen Act
  • S. 927
    Protecting Pharmacies in Medicaid Act
  • S. 1105
    No UPCODE Act
  • H.R. 4317
    PBM Reform Act of 2025
  • H.R. 2214
    DRUG Act
  • H.R. 5433
    POP Act
  • S. 2836
    POP Act
  • H.R. 4409
    Fair Pharmacies for Federal Employees Act of 2025
  • S. 2099
    Restore Prescription Drugs Discount Act
  • H.R. 2853
    Combating Organized Retail Crime Act of 2025
  • S. 1404
    Combating Organized Retail Crime Act
  • S. 2068
    End Prescription Drug Ads Now Act
  • H.R. 3789
    DTC Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem